Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era

Grace M Lee1, Susan S Huang, Sheryl L Rifas-Shiman

  • 1Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA. grace_lee@hphc.org

Abstract

Insights

Staphylococcus aureus and MRSA colonization remained stable in young children despite pneumococcal conjugate vaccine use. Recent antibiotic use was inversely associated with S. aureus nasal carriage.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Epidemiology

Background:

  • Rising incidence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in children.
  • Previous inverse association between Streptococcus pneumoniae and S. aureus colonization in unvaccinated children.
  • Limited data on S. aureus carriage risk factors post-heptavalent pneumococcal conjugate vaccine (PCV7) introduction.

Purpose of the Study:

  • Determine S. aureus and MRSA colonization prevalence in young children after widespread PCV7 use.
  • Examine risk factors for S. aureus colonization in the post-PCV7 era, including pneumococcal colonization status.

Main Methods:

  • Nasal swabs collected from children aged 3 months to <7 years in Massachusetts (2003-2004 and 2006-2007).
  • Identification of S. aureus and antibiotic susceptibility testing performed.
  • Multivariate mixed model analysis to identify risk factors for S. aureus colonization.

Main Results:

  • S. aureus colonization prevalence remained stable (14.6% vs. 14.1%) between study periods.
  • MRSA colonization remained low (0.2% vs. 0.9%, p=0.09).
  • Younger age and recent antibiotic use were significant predictors of S. aureus colonization.

Conclusions:

  • S. aureus and MRSA colonization rates were stable in children under 7 years old despite PCV7 use.
  • S. aureus nasal colonization varies by age.
  • Recent antibiotic use is inversely correlated with S. aureus nasal colonization.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...